Cargando…

Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial

PURPOSE: Topical cosmetic agents if correctly prescribed and used may improve outcomes in acne therapy. The aim of this study was to assess the efficacy and tolerability of a new daily cosmetic regimen in the treatment of mild facial acne. PATIENTS AND METHODS: A multicenter, prospective, observatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Dall’Oglio, Federica, Fabbrocini, Gabriella, Tedeschi, Aurora, Donnarumma, Marianna, Chiodini, Paolo, Micali, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997230/
https://www.ncbi.nlm.nih.gov/pubmed/32099436
http://dx.doi.org/10.2147/CCID.S206935
_version_ 1783493652542128128
author Dall’Oglio, Federica
Fabbrocini, Gabriella
Tedeschi, Aurora
Donnarumma, Marianna
Chiodini, Paolo
Micali, Giuseppe
author_facet Dall’Oglio, Federica
Fabbrocini, Gabriella
Tedeschi, Aurora
Donnarumma, Marianna
Chiodini, Paolo
Micali, Giuseppe
author_sort Dall’Oglio, Federica
collection PubMed
description PURPOSE: Topical cosmetic agents if correctly prescribed and used may improve outcomes in acne therapy. The aim of this study was to assess the efficacy and tolerability of a new daily cosmetic regimen in the treatment of mild facial acne. PATIENTS AND METHODS: A multicenter, prospective, observational, clinical study was conducted on 91 adult patients with mild acne. Subjects were instructed to apply a fluid containing Licochalcone A/Salicylic acid/L-Carnitine in the morning and a cream with Licochalcone A/Hydroxy-Complex 10% at bedtime for 8 weeks. The efficacy was clinically evaluated by Global Acne Grading System (GAGS) score and by comedones/papules lesions count and by instrumental assessment (Sebutape(TM)and Reveal Photo Imager/VISIA-CR™ imaging) at baseline, at 4 and 8 weeks. RESULTS: At 4 weeks a statistically significant reduction from baseline of GAGSwas observed. In addition, the mean total count of comedones and papules was significantly reduced by 41% and 45%, respectively, from baseline along with a significant reduction of mean sebum of 47%. At 8 weeks, a further statistically significant reduction from baseline of GAGS, total count of comedones and papules (64% and 71%, respectively), along with an additional sebum reduction of about 52% was also recorded. CONCLUSION: Our results suggest that the daily regimen based on Licochalcone A with Salicylic acid/L-Carnitine as fluid or with Hydroxy-Complex 10% as cream represent an interesting cosmetic approach for treating mild acne.
format Online
Article
Text
id pubmed-6997230
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-69972302020-02-25 Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial Dall’Oglio, Federica Fabbrocini, Gabriella Tedeschi, Aurora Donnarumma, Marianna Chiodini, Paolo Micali, Giuseppe Clin Cosmet Investig Dermatol Original Research PURPOSE: Topical cosmetic agents if correctly prescribed and used may improve outcomes in acne therapy. The aim of this study was to assess the efficacy and tolerability of a new daily cosmetic regimen in the treatment of mild facial acne. PATIENTS AND METHODS: A multicenter, prospective, observational, clinical study was conducted on 91 adult patients with mild acne. Subjects were instructed to apply a fluid containing Licochalcone A/Salicylic acid/L-Carnitine in the morning and a cream with Licochalcone A/Hydroxy-Complex 10% at bedtime for 8 weeks. The efficacy was clinically evaluated by Global Acne Grading System (GAGS) score and by comedones/papules lesions count and by instrumental assessment (Sebutape(TM)and Reveal Photo Imager/VISIA-CR™ imaging) at baseline, at 4 and 8 weeks. RESULTS: At 4 weeks a statistically significant reduction from baseline of GAGSwas observed. In addition, the mean total count of comedones and papules was significantly reduced by 41% and 45%, respectively, from baseline along with a significant reduction of mean sebum of 47%. At 8 weeks, a further statistically significant reduction from baseline of GAGS, total count of comedones and papules (64% and 71%, respectively), along with an additional sebum reduction of about 52% was also recorded. CONCLUSION: Our results suggest that the daily regimen based on Licochalcone A with Salicylic acid/L-Carnitine as fluid or with Hydroxy-Complex 10% as cream represent an interesting cosmetic approach for treating mild acne. Dove 2019-12-31 /pmc/articles/PMC6997230/ /pubmed/32099436 http://dx.doi.org/10.2147/CCID.S206935 Text en © 2019 Dall’Oglio et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Dall’Oglio, Federica
Fabbrocini, Gabriella
Tedeschi, Aurora
Donnarumma, Marianna
Chiodini, Paolo
Micali, Giuseppe
Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial
title Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial
title_full Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial
title_fullStr Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial
title_full_unstemmed Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial
title_short Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial
title_sort licochalcone a in combination with salicylic acid as fluid based and hydroxy-complex 10% cream for the treatment of mild acne: a multicenter prospective trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997230/
https://www.ncbi.nlm.nih.gov/pubmed/32099436
http://dx.doi.org/10.2147/CCID.S206935
work_keys_str_mv AT dallogliofederica licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial
AT fabbrocinigabriella licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial
AT tedeschiaurora licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial
AT donnarummamarianna licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial
AT chiodinipaolo licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial
AT micaligiuseppe licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial